Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients

Coronary artery bypass graft surgery provides better health status, quality of life in diabetic patients

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Anti-thrombotic therapy interruption has no influence on perioperative complications in cardiac patients

Anti-thrombotic therapy interruption has no influence on perioperative complications in cardiac patients

Pre-treatment with prasugrel increases risk of bleeding without reducing risk of ischemic events

Pre-treatment with prasugrel increases risk of bleeding without reducing risk of ischemic events

Research: General practitioners undertreat women with atrial fibrillation

Research: General practitioners undertreat women with atrial fibrillation

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Older heart patients present unique challenges for determining optimal dosages of medications

Older heart patients present unique challenges for determining optimal dosages of medications

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Dual antiplatelet therapy improves outcomes in patients undergoing coronary stenting

Dual antiplatelet therapy improves outcomes in patients undergoing coronary stenting

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Janssen receives complete response letter from FDA for XARELTO sNDA

Janssen receives complete response letter from FDA for XARELTO sNDA

Clinical study shows that clopidogrel not effective in infants with congenital heart diseases

Clinical study shows that clopidogrel not effective in infants with congenital heart diseases

Faster, more potent antithrombotic drugs recommended for high-risk heart attack patients

Faster, more potent antithrombotic drugs recommended for high-risk heart attack patients

New AAN guideline provides direction for use of blood thinners during surgery

New AAN guideline provides direction for use of blood thinners during surgery

University of Michigan Stroke Program study examines use of tPA in stroke patients

University of Michigan Stroke Program study examines use of tPA in stroke patients

STREAM trial: Treatment with tenecteplase before hospital transfer benefits some

STREAM trial: Treatment with tenecteplase before hospital transfer benefits some

Cangrelor solidly outperforms clopidogrel during percutaneous coronary intervention

Cangrelor solidly outperforms clopidogrel during percutaneous coronary intervention

Cangrelor more effective than clopidogrel in preventing blood clots

Cangrelor more effective than clopidogrel in preventing blood clots

Tranexamic acid role in coronary bypass surgery

Tranexamic acid role in coronary bypass surgery

WOEST supports clopidogrel only in PCI patients on anticoagulation

WOEST supports clopidogrel only in PCI patients on anticoagulation